Exhibit 99.2
UNAUDITED PRO FORMA COMBINED FINANCIAL INFORMATION
(Amounts in thousands of U.S. dollars)
The following unaudited pro forma combined balance sheet as of June 30, 2026 and the unaudited pro forma combined statement of operations
for the year ended December 31, 2025 and the six months ended June 30, 2026 present the financial information of FiscalNote Holdings, Inc. (“FiscalNote” or the “Company”) after giving effect to the sale by FiscalNote,
Inc., an indirect wholly-owned subsidiary of the Company, of its equity interests in Frontier Strategy Group, LLC (the “Disposition”) and related paydown of its senior term loan with proceeds received from the Disposition (collectively
with the sale of Oxford Analytica International Group (“Oxford Analytica”) and Dragonfly Eye Limited (“Dragonfly”), as described below (the “Transactions”)) and related adjustments described in the accompanying
notes.
The unaudited pro forma combined statement of operations for the year ended December 31, 2025 and the six months ended
June 30, 2026 gives pro forma effect to the Disposition and related transactions as if they had occurred on January 1, 2025. The unaudited pro forma combined statement of operations for the year ended December 31, 2025 also gives pro forma
effect to the sale of Oxford Analytica and Dragonfly as described under “Description of the Previously Reported Transactions” below. The unaudited pro forma combined balance sheet as of June 30, 2026 gives pro forma effect to the
Disposition and related transactions as if they were completed on June 30, 2026.
The unaudited pro forma combined financial
information is based on, and should be read in conjunction with, the audited historical financial statements of FiscalNote and the notes thereto for the year ended December 31, 2025, as well as the disclosures contained in the sections titled
“FiscalNote’s Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in the Company’s Annual Report on Form 10-K filed on March 24,
2026.
The unaudited pro forma combined financial information has been presented for illustrative purposes only and does not necessarily
reflect what FiscalNote’s financial condition or results of operations would have been had the Transactions occurred on the dates indicated. Further, the unaudited pro forma combined financial information also may not be useful in predicting
the future financial condition and results of operations of FiscalNote. The actual financial position and results of operations may differ significantly from the pro forma amounts reflected herein due to a variety of factors. The unaudited pro forma
adjustments represent management’s estimates based on information available as of the date of this Form 8-K and are subject to change as additional information becomes available and analyses are
performed.
Description of the Dispositions
Sale
of Frontier Strategy Group, LLC
On August 26, 2026, FiscalNote, Inc. (the “Seller”), an indirect wholly-owned
subsidiary of the Company, entered into an Equity Purchase Agreement (the “Purchase Agreement”) with Oxford Economics USA, Inc. (the “Buyer”), pursuant to which the Seller sold all of the outstanding equity interests of
Frontier Strategy Group, LLC to the Buyer for a base purchase price of $7.0 million, subject to customary post-closing adjustments (the “Equity Sale”); the Company received $6.4 million after certain working capital adjustments
and payment of transaction expenses. In addition, the Buyer agreed to make potential cash earn-out payments to the Seller in the amount of $3.0 million, less the amount of certain potential retention
payments to certain employees of the Company, subject to the achievement of certain annual recurring revenue targets in 2026. $1,055 of the base purchase price was deposited into escrow to satisfy certain potential post-closing purchase price
adjustments and indemnification claims.
The transaction accounting adjustments for the Disposition remove the assets, liabilities and
results of operations of Frontier Strategy Group, LLC and also give effect to adjustments to reflect the use of cash proceeds from the Buyer to pay down existing long-term debt as detailed below.
Sources and Uses of Funds
|
|
|
|
|
| Sources |
|
Amount |
|
| Base Purchase Price (a) |
|
$ |
7,000 |
|
| Cash from balance sheet |
|
|
295 |
|
| Less: Adjustments to Base Purchase Price (b) |
|
|
644 |
|
|
|
|
|
|
| Total Sources |
|
$ |
6,651 |
|
|
|
|
|
|
|
|
|
|
|
| Uses |
|
Amount |
|
| Debt paydown (c) |
|
$ |
5,000 |
|
| Escrow |
|
|
1,055 |
|
| Estimated fees and expenses (d) |
|
|
596 |
|
|
|
|
|
|
| Total Uses |
|
$ |
6,651 |
|
|
|
|
|
|
| (a) |
Reflects cash consideration pursuant to the Purchase Agreement. |
| (b) |
Reflects adjustments to the purchase price pursuant to the Purchase Agreement on account of working capital and
transaction expenses. |
| (c) |
Reflects payments for principal of $4,951 and accrued and unpaid interest of $49. |
| (d) |
Reflects estimated transaction costs consisting principally of accounting, tax, and legal advisors.
|
Description of the Previously Reported Transactions
Sale of Oxford Analytica and Dragonfly
On
February 21, 2025, FiscalNote, Inc. an indirect wholly-owned subsidiary of the Company, entered into an equity purchase agreement with Factiva Limited pursuant to which the FiscalNote, Inc. agreed to sell all of the outstanding equity interests
of Oxford Analytica and Dragonfly to the Factiva Limited for total consideration of $40.0 million in cash, subject to customary post-closing adjustments. The sale of Oxford Analytica and Dragonfly closed on March 31, 2025.
The transaction accounting adjustments for the Previously Reported Transactions remove the results of operations of Oxford Analytica and
Dragonfly. There are no pro forma adjustments for the unaudited pro forma combined balance sheet as of June 30, 2026 as the sale of Oxford Analytica and Dragonfly are already reflected in such balance sheet.